How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines

被引：7

作者：

Rudraraju, Rajeev ^{[1
]}

Mordant, Francesca ^{[1
]}

Subbarao, Kanta ^{[1
,2
]}

机构：

[1] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia

[2] Peter Doherty Inst Infect & Immun, WHO Collaborating Ctr Reference & Res Influenza, 792 Elizabeth St, Melbourne, Vic 3000, Australia

来源：

JOURNAL OF INFECTIOUS DISEASES | 2019年 / 219卷

关键词：

influenza; pandemic; seasonal; prime-boost; live attenuated influenza vaccine; COLD-ADAPTED INFLUENZA; A VIRUS NUCLEOPROTEIN; PHASE-I TRIAL; PROVIDES PROTECTION; SEASONAL INFLUENZA; GENETIC STABILITY; UNITED-STATES; IMMUNOGENICITY; ANTIBODY; CHILDREN;

D O I：

10.1093/infdis/jiy703

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：S81 / S87

页数：7

共 74 条

[1] STUDY OF LIVE RECOMBINANT COLD-ADAPTED INFLUENZA BIVALENT VACCINE OF TYPE-A FOR USE IN CHILDREN - AN EPIDEMIOLOGIC CONTROL TRIAL [J].

ALEXANDROVA, GI ;

BUDILOVSKY, GN ;

KOVAL, TA ;

POLEZHAEV, FI ;

GARMASHOVA, LM ;

GHENDON, YZ ;

ROMANOVA, YR ;

SMORODINTSEV, AA .

VACCINE, 1986, 4 (02) :114-118

[2] The role of nasal IgA in children vaccinated with live attenuated influenza vaccine [J].

Ambrose, Christopher S. ;

Wu, Xionghua ;

Jones, Taff ;

Mallory, Raburn M. .

VACCINE, 2012, 30 (48) :6794-6801

[3] Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine [J].

Babu, Tara M. ;

Levine, Min ;

Fitzgerald, Theresa ;

Luke, Catherine ;

Sangster, Mark Y. ;

Jin, Hong ;

Topham, David ;

Katz, Jacqueline ;

Treanor, John ;

Subbarao, Kanta .

VACCINE, 2014, 32 (50) :6798-6804

[4]

Bandell A, 2011, EXPERT REV VACCINES, V10, P1131, DOI [10.1586/ERV.11.73, 10.1586/erv.11.73]

[5] Nonreplicating Influenza A Virus Vaccines Confer Broad Protection against Lethal Challenge [J].

Baz, Mariana ;

Boonnak, Kobporn ;

Paskel, Myeisha ;

Santos, Celia ;

Powell, Timothy ;

Townsend, Alain ;

Subbarao, Kanta .

MBIO, 2015, 6 (05)

[6] Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine [J].

Belshe, RB ;

Gruber, WC ;

Mendelman, PM ;

Mehta, HB ;

Mahmood, K ;

Reisinger, K ;

Treanor, J ;

Zangwill, Z ;

Hayden, FG ;

Bernstein, DI ;

Kotloff, K ;

King, J ;

Piedra, PA ;

Block, SL ;

Yan, LH ;

Wolff, M .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (03) :1133-1137

[7] Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine [J].

Belshe, RB ;

Gruber, WC ;

Mendelman, PM ;

Cho, I ;

Reisinger, K ;

Block, SL ;

Wittes, J ;

Iacuzio, D ;

Piedra, P ;

Treanor, J ;

King, J ;

Kotloff, K ;

Bernstein, DI ;

Hayden, FG ;

Zangwill, K ;

Yan, LH ;

Wolff, M .

JOURNAL OF PEDIATRICS, 2000, 136 (02) :168-175

[8] Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age [J].

Block, Stan L. ;

Yogev, Ram ;

Hayden, Frederick G. ;

Ambrose, Christopher S. ;

Zeng, Wen ;

Walker, Robert E. .

VACCINE, 2008, 26 (38) :4940-4946

[9]

Broadbent AJ., 2015, Mucosal Immunology, P1129, DOI DOI 10.1016/B978-0-12-415847-4.00059-8

[10] Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates [J].

Broadbent, Andrew J. ;

Santos, Celia P. ;

Paskel, Myeisha ;

Matsuoka, Yumiko ;

Lu, Janine ;

Chen, Zhongying ;

Jin, Hong ;

Subbarao, Kanta .

VACCINE, 2015, 33 (01) :193-200

← 1 2 3 4 5 6 7 8 →